Photoacoustic detection of circulating melanoma cells in late stage patients

John A. Viator; Marc Hazur; Andrea Sajewski; Ahmad Tarhini; Martin E. San-ders; Robert H. Edgar

doi:10.1142/s1793545820500236

[1] M. Lens, M. Dawes, "Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma," British J. Dermatol. 150, 179–185 (2004).

[2] "Surveillance, epidemiology, and end results," https://seer.cancer.gov/statfacts/html/melan. html.

[3] J. Nieva, P. Kuhn, "Fluid biopsy for solid tumors: A patients companion for lifelong characterization of their disease," Future Oncology 8, 989–998 (2012).

[4] M. Cristofanilli, G. Budd, M. Ellis, A. Stopeck, J. Matera, M. Miller, J. Reuben, G. Doyle, W. Allard, L. Terstappen, "Circulating tumor cells, disease progression, and survival in metastatic breast cancer," New England J. Med. 351, 781–791 (2004).

[5] C. Economos, C. Morrissey, R. Vessella, "Circulating tumor cells as a marker of response: Implications for determining treatment efficacy and evaluating new agents," Cur. Opin. Urology 22, 190 (2012).

[6] M. Balic, H. Lin, A. Williams, R. Datar, R. Cote, "Progress in circulating tumor cell capture and analysis: Implications for cancer management," Exp. Rev. Mol. Diagnostics 12, 303–312 (2012).

[7] G. Steinert, S. Schólch, M. Koch, J. Weitz, "Biology and significance of circulating and disseminated tumour cells in colorectal cancer," Langenbeck's Arch. Surg. 397, 535–542 (2012).

[8] J. Doyen, C. Alix-Panabieres, P. Hofman, S. Parks, E. Chamorey, H. Naman, J. Hannoun-Levi, "Circulating tumor cells in prostate cancer: A potential surrogate marker of survival," Crit. Rev. Oncology/Hematology 81, 241–256 (2012).

[9] S. Mocellin, D. Hoon, A. Ambrosi, D. Nitti, C. Rossi, "The prognostic value of circulating tumor cells in patients with melanoma: A systematic review and meta-analysis," Clin. Cancer Res. 12, 4605–4613 (2006).

[10] M. Zborowski, J. Chalmers, "Rare cell separation and analysis by magnetic sorting," Anal. Chem. 83, 8050–8056 (2011).

[11] T. Autrey, S. Egerev, N. Foster, A. Fokin, O. Ovchinnikov, "Counting particles by means of optoacoustics: Potential limits in real solutions," Rev. Sci. Instrum. 74, 628 (2003).

[12] V. Vladimir, E. Galanzha, E. Shashkov, N. Khlebtsov, V. Tuchin, "In vivo photoacoustic flow cytometry for monitoring of circulating single cancer cells and contrast agents," Opt. Lett. 31, 3623–3625 (2006).

[13] E. Galanzha, Y. Menyaev, A. Yadem, M. Sarimollaoglu, M. Juratli, D. Nedosekin, S. Foster, A. Jamshidi-Parsian, E. Siegel, I. Makhoul, L. Hutchins, J. Suen, V. Zharov, "In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanoma," Sci. Trans. Med. 11, eaat5857 (2019).

[14] R. Weight, J. Viator, P. Dale, C. Caldwell, A. Lisle, "Photoacoustic detection of metastatic melanoma cells in the human circulatory system," Opt. Lett. 31, 2998–3000 (2006).

[15] J. Viator, S. Gupta, B. Goldschmidt, K. Bhattacharyya, R. Kannan, R. Shukla, P. Dale, E. Boote, K. Katti, "Gold nanoparticle mediated detection of prostate cancer cells using photoacoustic flowmetry with optical reflectance," J. Biomed. Nanotechnol. 6, 187–191 (2010).

[16] G. Gutierrez-Juarez, S. Gupta, M. Al-Shaer, L. Polo-Parada, P. Dale, C. Papageorgio, J. Viator, "Detection of melanoma cells in vitro using an optical detector of photoacoustic waves," Lasers Surg. Med. 42, 274–281 (2010).

[17] G. Gutierrez-Juarez, S. Gupta, R. Weight, L. Polo- Parada, C. Papagiorgio, J. Bunch, J. Viator, "Optical photoacoustic detection of circulating melanoma cells in vitro," Int. J. Thermophys. 31, 784–792 (2010).

[18] C. O'Brien, K. Rood, S. Shramik, K. G. Sagar, D. Thiago, C. Aaron, J. Viator, "Detection and isolation of circulating melanoma cells using photoacoustic flowmetry," J. Visualized Exp. 57, e3559 (2011).

[19] C. O'Brien, K. Rood, K. Bhattacharyya, T. DeSouza, S. Sengupta, S. Gupta, J. Mosley, B. Goldschmidt, N. Sharma, J. Viator, "Capture of circulating tumor cells using photoacoustic flowmetry and two phase flow," J. Biomed. Opt. 17, 061221–1 (2012).

[20] V. Muller, D. Hayes, K. Pantel, "Recent translational research: Circulating tumor cells in breast cancer patients," Breast Cancer Res. 8, 110 (2006).

[21] S. Steen, J. Nemunaitis, T. Fisher, J. Kuhn, "Circulating tumor cells in melanoma: A review of the literature and description of a novel technique," Proc. (Baylor Universiy Medical Center) 21, 127– 132 (2008).

[22] T. Gage, S. Fan, "What goes around, comes around: A review of circulating tumor cells," Analysis 11, 18 (2010).

[23] S. Swetter, Malignant melanoma (2008), www. emedicine.com/DERM/topic257.htm.

[24] E. Wain, C. Stefanato, R. Barlow, "A clinicopathological surprise: Amelanotic malignant melanoma," Clin. Exp. Dermatol. 33, 365–366 (2008).

[25] E. Punnoose, S. Atwal, J. Spoerke, H. Savage, A. Pandita, R. Yeh, A. Pirzkall, B. Fine, L. Amler, D. Chen, "Molecular biomarker analyses using circulating tumor cells," PLoS One 5, e12517 (2010).

[26] K. Koyanagi, S. O'Day, R. Gonzalex, K. Lewis, W. Robinson, T. Amatruda, H. Wang, R. Elasho?, H. Takeuchi, N. Umetani, D. Hoon, "Serial monitoring of circulating melanoma cells during neoadjuvent biochemotherapy for Stage III melanoma: Outcome prediction in a multicenter trial," J. Clin. Oncology 23, 8057–8064 (2005).

[27] S. Riethdorf, H. Fritsche, V. Müller, T. Rau, C. Schindl-beck, B. Rack, W. Janni, C. Coith, K. Beck, F. J?nicke, "Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system," Clin. Cancer Res. 13, 920 (2007).

[28] G. Vona, A. Sabile, M. Louha, V. Sitruk, S. Romana, K. Schutze, F. Capron, D. Franco, M. Pazzagli, M. Vekemans, "Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecularcharacterization of circulating tumor cells," Am. J. Pathology 156, 57 (2000).

[29] S. Nagrath, L. Sequist, S. Maheswaran, D. Bell, D. Irimia, L. Ulkus, M. Smith, E. Kwak, S. Digumarthy, A. Muzikansky, "Isolation of rare circulating tumour cells in cancer patients by microchip technology," Nature 450, 1235–1239 (2007).

[30] M. Dworzak, G. Froschl, D. Printz, G. Mann, U. Potschger, N. Muhlegger, G. Fritsch, H. Gadner, "Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia," Blood 99, 1952 (2002).

[31] P. Gascoyne, J. Noshari, T. Anderson, F. Becker, "Isolation of rare cells from cell mixtures by dielectrophoresis," Electrophoresis 30, 1388–1398 (2009).

[32] X. Hu, P. Bessette, J. Qian, C. Meinhart, P. Daugherty, H. Soh, "Marker-specific sorting of rare cells using dielectrophoresis," Proc. National Academy Sci. 102, 15757–15761 (2005).

[33] S. Nagrath, L. Sequist, S. Maheswaran, D. Bell, D. Irimia, L. Ulkus, M. Smith, E. Kwak, S. Digumarthy, A. Muzikansky, P. Ryan, U. Balias, R. Tompkins, S. Haber, M. Toner, "Isolation of rare circulating tumor cells in cancer patients by microchip technology," Nature 450, 1235–1239 (2007).

[34] S. Hou, H. Zhao, L. Zhao, Q. Shen, K. Wei, D. Suh, A. Nakao, M. Garcia, M. Song, T. Lee, "Capture and stimulated release of circulating tumor cells on polymer-grafted silicon nanostructures," Adv. Mater. 25, 1547–1551 (2012).

[35] D. Campana, E. Coustan-Smith, "Detection of minimal residual disease in acute leukemia by flow cytometry," Cytometry Part B: Clin. Cytometry 38, 139–152 (1999).

[36] P. Garstecki, M. Fuerstman, H. Stone, G. Whitesides, "Formation of droplets and bubbles in a microfluidic T-junctionscaling and mechanism of break-up," Lab Chip 6, 437–446 (2006).

[37] A. Lucci et al., "Circulating tumor cells and early relapse in node-positive melanoma," Clin. Cancer Res. 26, 1886–1895 (2020).